Capillary leak syndrome in a patient treated with interleukin 2 fusion toxin for cutaneous T-cell lymphoma.
Railan
D
D
Fivenson
D P
DP
Wittenberg
G
G
D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects*; D019559:Capillary Leak Syndrome / Q000139:chemically induced*; D004167:Diphtheria Toxin; D006801:Humans; D007376:Interleukin-2; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy*; D008297:Male; D011506:Proteins / Q000009:adverse effects*; D011993:Recombinant Fusion Proteins; D012878:Skin Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D004167:Diphtheria Toxin; D007376:Interleukin-2; D011506:Proteins; D011993:Recombinant Fusion Proteins; C078456:denileukin diftitox